Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 617

1.

Survival analysis in hematologic malignancies: recommendations for clinicians.

Delgado J, Pereira A, Villamor N, López-Guillermo A, Rozman C.

Haematologica. 2014 Sep;99(9):1410-20. doi: 10.3324/haematol.2013.100784. Review.

2.

A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.

Queirós AC, Villamor N, Clot G, Martinez-Trillos A, Kulis M, Navarro A, Penas EM, Jayne S, Majid A, Richter J, Bergmann AK, Kolarova J, Royo C, Russiñol N, Castellano G, Pinyol M, Bea S, Salaverria I, López-Guerra M, Colomer D, Aymerich M, Rozman M, Delgado J, Giné E, González-Díaz M, Puente XS, Siebert R, Dyer MJ, López-Otín C, Rozman C, Campo E, López-Guillermo A, Martín-Subero JI.

Leukemia. 2015 Mar;29(3):598-605. doi: 10.1038/leu.2014.252. Epub 2014 Aug 25.

PMID:
25151957
3.

Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome.

Martínez-Trillos A, Pinyol M, Navarro A, Aymerich M, Jares P, Juan M, Rozman M, Colomer D, Delgado J, Giné E, González-Díaz M, Hernández-Rivas JM, Colado E, Rayón C, Payer AR, Terol MJ, Navarro B, Quesada V, Puente XS, Rozman C, López-Otín C, Campo E, López-Guillermo A, Villamor N.

Blood. 2014 Jun 12;123(24):3790-6. doi: 10.1182/blood-2013-12-543306. Epub 2014 Apr 29.

4.

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior.

Giné E, Martinez A, Villamor N, López-Guillermo A, Camos M, Martinez D, Esteve J, Calvo X, Muntañola A, Abrisqueta P, Rozman M, Rozman C, Bosch F, Campo E, Montserrat E.

Haematologica. 2010 Sep;95(9):1526-33. doi: 10.3324/haematol.2010.022277. Epub 2010 Apr 26.

5.

Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience.

Abrisqueta P, Pereira A, Rozman C, Aymerich M, Giné E, Moreno C, Muntañola A, Rozman M, Villamor N, Hodgson K, Campo E, Bosch F, Montserrat E.

Blood. 2009 Sep 3;114(10):2044-50. doi: 10.1182/blood-2009-04-214346. Epub 2009 Jun 24.

6.

Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation.

Granell M, Urbano-Ispizua A, Pons A, Aróstegui JI, Gel B, Navarro A, Jansa S, Artells R, Gaya A, Talarn C, Fernández-Avilés F, Martínez C, Rovira M, Carreras E, Rozman C, Juan M, Yagüe J, Montserrat E, Monzó M.

Blood. 2008 Nov 15;112(10):4337-42. doi: 10.1182/blood-2007-12-129247. Epub 2008 Sep 4.

7.

Central nervous system involvement in mantle cell lymphoma.

Ferrer A, Bosch F, Villamor N, Rozman M, Graus F, Gutiérrez G, Mercadal S, Campo E, Rozman C, López-Guillermo A, Montserrat E.

Ann Oncol. 2008 Jan;19(1):135-41. Epub 2007 Oct 24.

PMID:
17962207
8.

Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation.

Granell M, Urbano-Ispizua A, Suarez B, Rovira M, Fernández-Avilés F, Martínez C, Ortega M, Uriburu C, Gaya A, Roncero JM, Navarro A, Carreras E, Mensa J, Vives J, Rozman C, Montserrat E, Lozano F.

Exp Hematol. 2006 Oct;34(10):1435-41.

PMID:
16982337
9.

[University of Health Sciences: legal aspects of a new option].

Rozman C, Lafarga Traver JL.

Med Clin (Barc). 2005 Apr 9;124(13):499-503. Spanish. No abstract available.

PMID:
15847769
10.

[Thoughts on biomedical research in Spain].

Rozman C.

Med Clin (Barc). 2003 Jan 18;120(1):19-23. Spanish. No abstract available.

PMID:
12525301
11.

Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings.

Abella E, Feliu E, Granada I, Millá F, Oriol A, Ribera JM, Sánchez-Planell L, Berga LI, Reverter JC, Rozman C.

Am J Clin Pathol. 2002 Oct;118(4):582-8.

PMID:
12375646
12.

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.

Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaerts MA, Goldman J, Champlin RE, Keating A, Weisdorf DJ, de Witte TM, Horowitz MM.

Blood. 2002 Sep 15;100(6):1997-2004.

13.

Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings.

Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la Rubia J, Brunet S, Pérez-Oteyza J, Ferrá C, Zuazu J, Caballero D, Bargay J, Carvalhais A, Díez JL, Espigado I, Alegre A, Rovira M, Campilho F, Odriozola J, Sanz MA, Sierra J, García-Conde J, Montserrat E; Spanish Group for Allogeneic Peripheral Blood Transplantation (Grupo Español de Trasplante Hemopoyético) and Instituto Português de Oncologia-Porto.

Blood. 2002 Jul 15;100(2):724-7.

14.

Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients.

Bladé J, San Miguel JF, Fontanillas M, Esteve J, Maldonado J, Alcalá A, Brunet S, García-Conde J, Besalduch J, Moro MJ, Fernández-Calvo J, Conde E, Font L, Gardella S, Carnero M, Carbonell F, Martí JM, Hernández-Martín J, Ortega F, Besses C, Ribera JM, Trujillo J, Escudero ML, Rozman C, Estapé J, Montserrat E.

Hematol J. 2001;2(4):272-8.

PMID:
11920260
15.

[Promotion of biomedical research in Spanish university hospitals].

Rozman C, Rodés J.

Med Clin (Barc). 2001 Oct 20;117(12):460-2. Spanish. No abstract available.

PMID:
11674973
16.

Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation.

Urbano-Ispizua A, Brunet S, Solano C, Moraleda JM, Rovira M, Zuazu J, de La Rubia J, Bargay J, Caballero D, Díez-Martín JL, Ojeda E, Pérez de Oteiza JP, Ferrá C, Espigado I, Alegre A, de La Serna J, Torres P, Riu C, Odriozola J, Rozman C, Sierra J, García-Conde J, Montserrat E; Spanish Group of Allo-PBT.

Bone Marrow Transplant. 2001 Aug;28(4):349-54.

17.

Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies.

Brunet S, Urbano-Ispizua A, Ojeda E, Ruiz D, Moraleda JM, Díaz MA, Caballero D, Bargay J, de la Rubia J, Solano C, Zuazu J, Diez JL, de la Serna J, Espigado I, Alegre A, Torres JP, Jurado M, Fernández M, Vivancos P, Carreras E, Hernández F, Maldonado J, Sierra J, Rozman C; Spanish Group of Allogenic-PBT, Spain.

Br J Haematol. 2001 Sep;114(3):544-50.

PMID:
11552978
18.

[Health Sciences University: an innovatory option?].

Rozman C.

Med Clin (Barc). 2000 Sep 30;115(10):381-3. Spanish. No abstract available.

PMID:
11262356
19.

[Non-Hodgkin's lymphomas: current aspects].

Rozman C.

Rev Neurol. 2000 Dec 16-31;31(12):1275-80. Review. Spanish.

PMID:
11205577
20.

The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings.

Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la Rubia J, Brunet S, Pérez-Oteiza J, Ferrá C, Zuazu J, Caballero D, Carvalhais A, Díez JL, Espigado I, Martínez C, Campilho F, Sanz MA, Sierra J, García-Conde J, Montserrat E; Spanish Group for Allogenic Peripheral Blood Transplantation.

Blood. 2001 Jan 15;97(2):383-7.

21.

Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation.

Martínez C, Urbano-Ispizua A, Rovira M, Carreras E, Rozman C, Montserrat E.

Leuk Lymphoma. 2000 May;37(5-6):535-42. Review.

PMID:
11042513
22.

Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation.

Simonsson B, Tötterman T, Hokland P, Lauria F, Carella AM, Fernandez MN, Rozman C, Ferrant A, de Witte T, Zander AR, Meier K, Hansson F, Nilsson BI.

Bone Marrow Transplant. 2000 Jun;25(11):1121-7.

23.

[Evidence-based medicine].

Rozman C, Foz M.

Med Clin (Barc). 1999;112 Suppl 1:1-2. Spanish. No abstract available.

PMID:
10618791
24.

Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.

Hernández-Boluda JC, Marín P, Carreras E, Aguilar JL, Grañena A, Rozman C, Montserrat E.

Haematologica. 1999 Jan;84(1):26-31.

25.

Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.

Martínez C, Urbano-Ispizua A, Rozman C, Marín P, Rovira M, Sierra J, Montfort N, Carreras E, Montserrat E.

Exp Hematol. 1999 Mar;27(3):561-8.

PMID:
10089920
26.

Magnetic resonance imaging in myelofibrosis and essential thrombocythaemia: contribution to differential diagnosis.

Rozman C, Cervantes F, Rozman M, Mercader JM, Montserrat E.

Br J Haematol. 1999 Mar;104(3):574-80.

PMID:
10086797
27.

Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients.

Besses C, Cervantes F, Pereira A, Florensa L, Solé F, Hernández-Boluda JC, Woessner S, Sans-Sabrafen J, Rozman C, Montserrat E.

Leukemia. 1999 Feb;13(2):150-4.

PMID:
10025886
28.

Pulmonary Langerhans' cell histiocytosis following autologous haemopoietic progenitor cell transplantation.

Soler N, Barberà JA, Ramirez J, Batllé M, Rozman C, Rodriguez-Roisin R.

Respir Med. 1998 Oct;92(10):1253-5. No abstract available.

29.

[1998: the year of Dr. A. Pedro-Pons].

Rozman C, Foz M.

Med Clin (Barc). 1998 Dec 12;111(20):783-4. Spanish. No abstract available.

PMID:
9922970
30.

Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.

Solano C, Martinez C, Brunet S, Tomás JF, Urbano-Ispizua A, Zuazu J, Ojeda E, Bargay J, Moraleda JM, Bailen A, Sierra J, García-Conde J, Rozman C.

Bone Marrow Transplant. 1998 Dec;22(12):1129-35.

31.

Haematology. Important steps forward.

Montserrat E, Rozman C.

Lancet. 1998 Dec 19-26;352 Suppl 4:SIV13. Review. No abstract available.

PMID:
9872160
32.

[Internal medicine textbooks: past, present, and future].

Rozman C.

Med Clin (Barc). 1998 Sep 19;111(8):298-301. Spanish. No abstract available.

PMID:
9810549
33.

Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution.

Bladé J, Fernández-Llama P, Bosch F, Montolíu J, Lens XM, Montoto S, Cases A, Darnell A, Rozman C, Montserrat E.

Arch Intern Med. 1998 Sep 28;158(17):1889-93.

PMID:
9759684
34.

Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT.

Urbano-Ispizua A, Solano C, Brunet S, de la Rubia J, Odriozola J, Zuazu J, Figuera A, Caballero D, Martínez C, García J, Sanz G, Torrabadella M, Alegre A, Pérez-Oteiza J, Jurado M, Oyonarte S, Sierra J, García-Conde J, Rozman C.

Bone Marrow Transplant. 1998 Sep;22(6):519-25.

35.

Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBT.

Urbano-Ispizua A, Solano C, Brunet S, de la Rubia J, Odriozola J, Zuazu J, Figuera A, Caballero D, Martínez C, García J, Sanz G, Torrabadella M, Alegre A, Pérez-Oteiza J, Jurado M, Oyonarte S, Sierra J, García-Conde J, Rozman C.

Bone Marrow Transplant. 1998 Jun;21 Suppl 3:S71-4.

PMID:
9712500
36.

Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology).

Bladé J, San Miguel JF, Escudero ML, Fontanillas M, Besalduch J, Gardella S, Arias J, García-Conde J, Carnero M, Marti JM, Rozman C, Estapé J, Montserrat E.

Leukemia. 1998 Jul;12(7):1144-8.

PMID:
9665202
37.

High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.

Briones J, Urbano-Ispizua A, Lawler M, Rozman C, Gardiner N, Marín P, Salgado C, Féliz P, McCann S, Montserrat E.

Exp Hematol. 1998 May;26(5):415-20.

PMID:
9590658
38.

[Contribution of magnetic resonance to the differential diagnosis of a collapsed vertebra in a patient with multiple myeloma].

Sanz L, Bladé J, Olondo M, Rozman M, Mercader JM, Rozman C, Montserrat E.

Sangre (Barc). 1998 Feb;43(1):77-81. Spanish.

PMID:
9577186
39.

The changing profile of idiopathic myelofibrosis: a comparison of the presenting features of patients diagnosed in two different decades.

Cervantes F, Pereira A, Esteve J, Cobo F, Rozman C, Montserrat E.

Eur J Haematol. 1998 Feb;60(2):101-5.

PMID:
9508350
40.

High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT.

Urbano-Ispizua A, García-Conde J, Brunet S, Hernández F, Sanz G, Petit J, Bargay J, Figuera A, Rovira M, Solano C, Ojeda E, de la Rubia J, Rozman C.

Haematologica. 1997 Nov-Dec;82(6):683-9.

41.

Demonstration of donor origin of CD34+ HLA-DR- bone marrow cells after allogeneic peripheral blood transplantation with a long follow-up.

Briones J, Urbano-Ispizua A, Orfao A, Marín P, Sierra J, Rovira M, Carreras E, Rozman C, Montserrat E.

Bone Marrow Transplant. 1998 Jan;21(2):189-94.

42.

[Idiopathic myelofibrosis: initial features, evolutive patterns and survival in a series of 106 patients].

Cervantes F, Pereira A, Esteve J, Cobo F, Rozman C, Montserrat E.

Med Clin (Barc). 1997 Nov 15;109(17):651-5. Spanish.

PMID:
9488952
43.

Haematology. The periphery is now central.

Rozman C, Sierra J.

Lancet. 1997 Dec 20-27;350 Suppl 3:SIII9. Review. No abstract available.

PMID:
9465185
44.

[Biomedical research in Spain and Medicina Clinica].

Rozman C, Foz M.

Med Clin (Barc). 1997 Oct 18;109(13):512. Spanish. No abstract available.

PMID:
9379743
45.

[Second allogeneic progenitor cell transplantation for leukemia relapse: results in 10 patients].

Martínez C, Carreras E, Sierra J, Rovira M, Urbano-Ispizua A, Viguria MC, Vela D, Rozman C, Montserrat E.

Med Clin (Barc). 1997 Oct 4;109(11):401-5. Spanish.

PMID:
9379728
46.

'Lymphoid' blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features.

Cervantes F, Villamor N, Esteve J, Montoto S, Rives S, Rozman C, Montserrat E.

Br J Haematol. 1998 Jan;100(1):123-8.

PMID:
9450800
47.

Expression of the adhesion molecule ICAM-1 in non-Hodgkin's lymphoma: relationship with tumor dissemination and prognostic importance.

Terol MJ, López-Guillermo A, Bosch F, Villamor N, Cid MC, Rozman C, Campo E, Montserrat E.

J Clin Oncol. 1998 Jan;16(1):35-40.

PMID:
9440720
48.

The Syndrome of Veno-occlusive Disease After Blood or Marrow Transplantation.

Carreras E, Rozman C.

Hematology. 1998;3(4):303-14. doi: 10.1080/10245332.1998.11746403.

PMID:
27413883
49.

Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy.

Zhang MJ, Baccarani M, Gale RP, McGlave PB, Atkinson K, Champlin RE, Dicke KA, Giralt S, Gluckman E, Goldman JM, Klein JP, Herzig RH, Masaoka T, O'Reilly RJ, Rozman C, Rowlings PA, Sobocinski KA, Speck B, Zwaan FE, Horowitz MM.

Br J Haematol. 1997 Oct;99(1):23-9.

PMID:
9359497
50.

Immunophenotypic and ultrastructural study in peripheral blood neutrophil granulocytes following bone marrow transplantation.

Masat T, Feliu E, Villamor N, Castellsagué J, Ordi J, Fabregues M, Rozman C.

Br J Haematol. 1997 Aug;98(2):299-307.

PMID:
9266924

Supplemental Content

Loading ...
Support Center